These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Cytotoxic cholesterol is generated by the hydrolysis of cytoplasmic cholesteryl ester and transported to the plasma membrane. Kellner-Weibel G; Geng YJ; Rothblat GH Atherosclerosis; 1999 Oct; 146(2):309-19. PubMed ID: 10532697 [TBL] [Abstract][Full Text] [Related]
4. Cytotoxic cellular cholesterol is selectively removed by apoA-I via ABCA1. Kellner-Weibel G; Luke SJ; Rothblat GH Atherosclerosis; 2003 Dec; 171(2):235-43. PubMed ID: 14644392 [TBL] [Abstract][Full Text] [Related]
5. Novel effects of the acyl-coenzyme A:Cholesterol acyltransferase inhibitor 58-035 on foam cell development in primary human monocyte-derived macrophages. Rodriguez A; Bachorik PS; Wee SB Arterioscler Thromb Vasc Biol; 1999 Sep; 19(9):2199-206. PubMed ID: 10479663 [TBL] [Abstract][Full Text] [Related]
6. Protein synthesis inhibition in mouse peritoneal macrophages results in increased acyl coenzyme A:cholesterol acyl transferase activity and cholesteryl ester accumulation in the presence of native low density lipoprotein. Tabas I; Boykow GC J Biol Chem; 1987 Sep; 262(25):12175-81. PubMed ID: 3624250 [TBL] [Abstract][Full Text] [Related]
7. Cholesterol metabolism and efflux in human THP-1 macrophages. Kritharides L; Christian A; Stoudt G; Morel D; Rothblat GH Arterioscler Thromb Vasc Biol; 1998 Oct; 18(10):1589-99. PubMed ID: 9763531 [TBL] [Abstract][Full Text] [Related]
8. Cell toxicity induced by inhibition of acyl coenzyme A:cholesterol acyltransferase and accumulation of unesterified cholesterol. Warner GJ; Stoudt G; Bamberger M; Johnson WJ; Rothblat GH J Biol Chem; 1995 Mar; 270(11):5772-8. PubMed ID: 7890706 [TBL] [Abstract][Full Text] [Related]
9. Exposure of rat peritoneal macrophages to acetylated low density lipoprotein results in release of plasma membrane cholesterol. An efficient substrate for esterification by acyl-CoA:cholesterol acyltransferase. Shinohara M; Miyazaki A; Shichiri M; Morino Y; Horiuchi S J Biol Chem; 1992 Jan; 267(3):1603-8. PubMed ID: 1730705 [TBL] [Abstract][Full Text] [Related]
10. Effects of NTE-122, a novel acyl-CoA:cholesterol acyltransferase inhibitor, on cholesterol esterification and high-density lipoprotein-induced cholesterol efflux in macrophages. Azuma Y; Kawasaki T; Ikemoto K; Ohno K; Yamada T; Yamasaki M; Nobuhara Y Jpn J Pharmacol; 1999 Feb; 79(2):159-67. PubMed ID: 10202851 [TBL] [Abstract][Full Text] [Related]
11. Impaired mobilisation of cholesterol from stored cholesteryl esters in human (THP-1) macrophages. Graham A; Angell AD; Jepson CA; Yeaman SJ; Hassall DG Atherosclerosis; 1996 Feb; 120(1-2):135-45. PubMed ID: 8645354 [TBL] [Abstract][Full Text] [Related]
12. Cholesterol transport from plasma membranes to intracellular membranes is inhibited by 3 beta-[2-(diethylamino)ethoxy]androst-5-en-17-one. Härmälä AS; Pörn MI; Mattjus P; Slotte JP Biochim Biophys Acta; 1994 Mar; 1211(3):317-25. PubMed ID: 8130265 [TBL] [Abstract][Full Text] [Related]
13. Incorporation of lipoxygenase products into cholesteryl esters by acyl-CoA:cholesterol acyltransferase in cholesterol-rich macrophages. Mathur SN; Albright E; Field FJ Biochem J; 1988 Dec; 256(3):807-14. PubMed ID: 3223954 [TBL] [Abstract][Full Text] [Related]
14. Effect of the ACAT inhibitor, HL-004, on cholesterol metabolism in macrophages. Murakami S; Yamagishi I; Asami Y; Sato M; Tomisawa K Cell Mol Biol (Noisy-le-grand); 1996 Sep; 42(6):865-72. PubMed ID: 8891354 [TBL] [Abstract][Full Text] [Related]
15. ACAT1 deficiency disrupts cholesterol efflux and alters cellular morphology in macrophages. Dove DE; Su YR; Zhang W; Jerome WG; Swift LL; Linton MF; Fazio S Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):128-34. PubMed ID: 15499044 [TBL] [Abstract][Full Text] [Related]
16. ABCA1-mediated cholesterol efflux is defective in free cholesterol-loaded macrophages. Mechanism involves enhanced ABCA1 degradation in a process requiring full NPC1 activity. Feng B; Tabas I J Biol Chem; 2002 Nov; 277(45):43271-80. PubMed ID: 12215451 [TBL] [Abstract][Full Text] [Related]
17. Effects of an anti-oxidative ACAT inhibitor on apoptosis/necrosis and cholesterol accumulation under oxidative stress in THP-1 cell-derived foam cells. Miike T; Shirahase H; Jino H; Kunishiro K; Kanda M; Kurahashi K Life Sci; 2008 Jan; 82(1-2):79-84. PubMed ID: 18037448 [TBL] [Abstract][Full Text] [Related]
18. Preferential pharmacological inhibition of macrophage ACAT increases plaque formation in mouse and rabbit models of atherogenesis. Perrey S; Legendre C; Matsuura A; Guffroy C; Binet J; Ohbayashi S; Tanaka T; Ortuno JC; Matsukura T; Laugel T; Padovani P; Bellamy F; Edgar AD Atherosclerosis; 2001 Apr; 155(2):359-70. PubMed ID: 11254906 [TBL] [Abstract][Full Text] [Related]